← Insider buys
RNA

Atrium Therapeutics, Inc. · Healthcare

President and CEO Sarah Boyce sold $619K of Atrium Therapeutics, Inc.

Sold$619,444
$72.23Price
8,576Shares
−3%Stake

What RNA did after the filing

Prices for RNA after this filing aren't in yet.

Traded Wed, Jan 7. Filed Fri, Jan 9, 12:13 PM ET, during the session. Not investment advice.